Emerging MedTech Companies Database & Market Intelligence | Life Science Intelligence

Access a comprehensive database of emerging medtech companies through Life Science Intelligence Compass. Track rising innovators, evaluate competitive landscapes, and analyze company growth trajectories across the global healthcare technology market. Gain visibility into funding rounds, strategic partnerships, product development initiatives, and commercialization strategies.

Visit us https://www.lifesciencemarketresearch.com/compass

MedTech Investors Database & Investment Insights | Life Science Intelligence

Access a powerful database of medtech investors through Life Science Intelligence Compass, built to help you navigate the complex investment landscape. Discover detailed profiles of active investors, their funding focus, deal history, and sector preferences. Track capital flow, evaluate investment trends, and identify potential partners for growth and innovation.

Visit us :https://www.lifesciencemarketresearch.com/compass

Cardiac Rhythm Management Devices Market – Growth & Insights

The cardiac rhythm management devices market continues to expand, driven by rising cardiovascular disease rates and technological advancements. Covering pacemakers, implantable defibrillators, and cardiac monitors, this sector plays a vital role in saving lives. Learn about market trends, key players, regulatory updates, and innovations shaping the future of cardiac care.

Visit us https://www.lifesciencemarketr....esearch.com/insights

The Weekly Recap 2/14/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward


LSI Alumni achieved major milestones this week, securing $41M+ in funding, regulatory approvals, and key partnerships ahead of LSI USA ‘25. Highlights include Accelus’ ANVISA approval for FlareHawk, Exero Medical’s $12.7M funding, and IBEX Medical Analytics’ FDA clearance for Ibex Prostate. Leadership changes, AI advancements, and medtech innovations continue to drive growth.

Visit us https://www.lifesciencemarketr....esearch.com/insights

Innovator Spotlight: CardiaCare CEO Amir Soltanianzadeh on Disrupting AF Therapy

From medtech founder to investor and now CEO of CardiaCare, Amir Soltanianzadeh is leading a revolution in atrial fibrillation care with a non-invasive, AI-powered neuromodulation device. With strong clinical data and a Series A raise underway, he’s advancing digital therapeutics for scalable, patient-centered care.

Visit us https://www.lifesciencemarketr....esearch.com/insights